From: Prevalence of QT prolongation and its risk factors in patients with type 2 diabetes
Predictors | B | OR (ExpB) | 95% CI | P value$ |
---|---|---|---|---|
Nephropathy | 0.251 | 1.285 | 0.766–2.158 | 0.342 |
CVD | 0.556 | 1.761 | 1.021–3.036 | 0.042* |
Hypertension | −0.190 | 0.827 | 0.482–1.419 | 0.490 |
BMI | 0.025 | 1.025 | 0.988–1.064 | 0.188 |
LDL-C | 0.016 | 1.016 | 0.656–1.574 | 0.944 |
Total cholesterol | −0.163 | 0.849 | 0.581–1.241 | 0.398 |
Insulin | 0.271 | 1.312 | 0.590–2.917 | 0.506 |
Anti-platelet medications | 0.254 | 1.289 | 0.789–2.108 | 0.311 |
Loop diuretics | 0.809 | 2.245 | 1.023–4.923 | 0.044* |
Potassium-sparing diuretics | 1.047 | 2.849 | 0.345–23.518 | 0.331 |